Ophthalmic devices are those devices which are used for vision correction or in ophthalmic diagnostic procedures. A corneal implant is a naturally based or artificially engineered cornea that is implanted onto an eye of a patient to replace his or her damaged or diseased cornea. GlobalData uses proprietary data and analytics to provide a comprehensive report on the corneal implants market in China. Buy the latest report here.
In 2022, GlobalData’s Market Model methodology determined that the leading player in the corneal implants market in China was AJL Ophthalmic followed by Lions Eye Institute and Massachusetts Eye and Ear Infirmary.
Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.
Corneal Grafts, Keratoprostheses and Intrastromal Corneal Rings Segment (ICRS) are tracked under this market.
The corneal implants market in China can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.
For the latest analysis of the market size corneal implants in China, buy the report here.